InvestorsHub Logo
Followers 275
Posts 35670
Boards Moderated 2
Alias Born 04/05/2012

Re: JohnCM post# 417

Friday, 07/09/2021 11:26:55 AM

Friday, July 09, 2021 11:26:55 AM

Post# of 437
CATB $2.02 Data Coming Tuesday **-> BOSTON, July 07, 2021--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will present a corporate overview and provide information on its lead program QLS-215, which is in preclinical development for the treatment of hereditary angioedema, at the upcoming virtual Ladenburg Thalmann Healthcare Conference. The presentation will take place on Tuesday, July 13th, 2021 at 12:30pm ET.



D1sclaimer: I am not a financial advisor or a stock promoter. I am an investor, Period! Do your own DD and make your own investment decisions.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.